VCAM1 and inflammatory response: In a study characterising the roles of ICAM-1 and VCAM-1 during colitis, Sans et al [50] highlighted the therapeutic potential of VCAM-1 antibody blockade for preventing pathological leukocyte infiltration and associated intestinal inflammation.